Jane Peters
Centre for Drug Research and Development(CA)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma(2016)161 cited
- → Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors(2012)73 cited
- Pseudolymphoma of the lung: a rare cause of a solitary nodule. A case report and review of the literature.(1980)
- → Intratesticular Lipoma(2002)12 cited
- → THE EFFECT OF DELAYED ANALYSIS OR FREEZE-THAWING ON THE MEASUREMENT OF NATURAL ANTICOAGULANTS, RESISTANCE TO ACTIVATED PROTEIN C AND MARKERS OF ACTIVATION OF THE HAEMOSTATIC SYSTEM(1997)11 cited
- → 262 A COMPARISON OF OPEN RADICAL NEPHRECTOMY COMPLICATION RATES IN PATIENTS TREATED WITH NEOADJUVANT SUNITINIB FOR METASTATIC RENAL CELL CARCINOMA VERSUS NON-METASTATIC RENAL CELL CARCINOMA(2011)1 cited
- → Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience.(2015)1 cited
- → Metformin use is associated with earlier stage at diagnosis in ovarian cancer patients(2014)
- → 578 Predictive markers for breast cancers of limited extent(2010)